Latest filing published 13 Nov 2023 for Nextgen Healthcare, INC..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Mitchell Waters, listed as chief executive, appears in our data through filings on Nextgen Healthcare, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 1 June 2021 to 9 November 2023, the count stands at 28 filings.
On the market, this insider has only sold: 7 sales, €441k in total. Besides market trades, the filings include 18 share grants and 2 option exercises.
Most recently, on 13 November 2023, the filings show a transaction in Nextgen Healthcare, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations